نتائج البحث - Allan Gaw

  • يعرض 1 - 7 نتائج من 7
تنقيح النتائج
  1. 1
    Are Routinely Collected NHS Administrative Records Suitable for Endpoint Identification in Clinical Trials? Evidence from the West of Scotland Coronary Prevention Study

    Are Routinely Collected NHS Administrative Records Suitable for Endpoint Identification in Clinical Trials? Evidence from the West of Scotland Coronary Prevention Study حسب Sarah Barry, Eleanor Dinnett, Sharon Kean, Allan Gaw, Ian Ford

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

    Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) حسب A. Michael Wallace, Alex D. McMahon, Chris J. Packard, Anne M. Kelly, James Shepherd, Allan Gaw, Naveed Sattar

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study

    C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study حسب Dilys J. Freeman, John Norrie, Muriel Caslake, Allan Gaw, Ian Ford, Gordon Lowe, D S O’Reilly, Chris J. Packard, Naveed Sattar

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

    Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study حسب Naveed Sattar, Allan Gaw, Olga Scherbakova, Ian Ford, D S O’Reilly, Steven M. Haffner, Chris Isles, Peter W. Macfarlane, Chris J. Packard, Stuart M. Cobbe, James Shepherd

    منشور في 2003
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Pravastatin and the Development of Diabetes Mellitus

    Pravastatin and the Development of Diabetes Mellitus حسب Dilys J. Freeman, John Norrie, Naveed Sattar, R. Dermot G. Neely, Stuart M. Cobbe, Ian Ford, Christopher Isles, A R Lorimer, Peter W. Macfarlane, James H. McKillop, Christopher J. Packard, James Shepherd, Allan Gaw

    منشور في 2001
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

    Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) حسب Chris J. Packard, Ian Ford, Michele Robertson, James Shepherd, Gerard J. Blauw, Michael Murphy, Edward Bollen, Brendan M. Buckley, Stuart M. Cobbe, Allan Gaw, Michael E. Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, Ivan J. Perry, David J. Stott, Brian Sweeney, C. Twomey, Rudi G. J. Westendorp

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Association Between Apolipoprotein E<sub>4</sub> and Cognitive Decline in Elderly Adults

    Association Between Apolipoprotein E<sub>4</sub> and Cognitive Decline in Elderly Adults حسب Chris J. Packard, Rudi G. J. Westendorp, David J. Stott, Muriel Caslake, Heather Murray, James Shepherd, Gerard J. Blauw, Michael Murphy, Edward Bollen, Brendan M. Buckley, Stuart M. Cobbe, Ian Ford, Allan Gaw, Michael E. Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, J. Jolles, Ivan J. Perry, Brian Sweeney, C. Twomey

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: